Status:
RECRUITING
The 3rd COPENHAGEN Puberty Study
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Environmental Protection Agency (EPA)
European Commission
Conditions:
Puberty
Puberty, Precocious
Eligibility:
All Genders
5-19 years
Brief Summary
The COPENHAGEN School Study is a combined cross-sectional and longitudinal study of healthy Danish school children. This study will by clinical examinations and withdrawal of blood samples investigate...
Detailed Description
Cross-sectional School study: All children will be examined once and the following data will be collected: 1. Clinical medical examination of the child consisting of height measurements (standing- a...
Eligibility Criteria
Inclusion
- Healthy children and adolescents
Exclusion
- In case of acute disease, cancer, cancer therapy, or chronic disease (History of malignant disease, chemotherapy or radiation, cystic fibrosis, juvenile rheumatoid arthritis, systemic lupus erythematosus, sickle cell disease, thalassemia, chronic renal disease or known numerical chromosome aberration)
- Non-Caucasian
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2056
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04884620
Start Date
January 1 2023
End Date
December 31 2056
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Department of Growth and Reproduction
Copenhagen, Denmark, 2100